Biofrontera Aktie

Biofrontera für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 604611 / ISIN: DE0006046113

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
13.08.2025 23:50:55

Biofrontera Revenue Jumps 15% in Q2

Biofrontera (NASDAQ:BFRI), a specialty biopharmaceutical company focused on dermatology solutions, released its financial results for the second quarter of fiscal 2025 on August 13, 2025. The headline news was a jump in revenue—totaling $9.0 million (GAAP)—which outpaced analyst expectations of $8.3 million, resulting in an 8.4% beat. Sales were driven by higher demand and improved pricing for Ameluz®, its main product. Despite the revenue growth and evidence of commercial progress, the bottom line moved in the opposite direction. Biofrontera posted a net loss per share of $(0.57) (GAAP), missing the consensus estimate of $(0.42). The wider loss was largely the result of a significant increase in legal expenses. Overall, the quarter showed top-line momentum but highlighted ongoing challenges with profitability and cost control. Source: Analyst estimates for the quarter provided by FactSet. Biofrontera develops and markets dermatological drugs and medical devices to treat skin conditions, with a main focus on actinic keratosis—a type of pre-cancerous skin lesion. Its principal product, Ameluz®, is a prescription medicine used with the company’s RhodoLED® photodynamic therapy (PDT) lamps for skin treatments.Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Analysen zu Q2 Holdings Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Q2 Holdings Inc 57,00 0,00% Q2 Holdings Inc